Actinic (Solar) Keratosis Global Clinical Trials Review 2024: Top Countries, Trial Status, Trial Phase, Sponsor Type and End-Point Status Dublin, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The "Actinic (Solar) Keratosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical...

Global Actinic Keratosis Treatment Market Analysis, Share, Growth, Trends and Forecast to 2031, Featuring Sun Pharmaceutical, Biofrontera, Nestle, Novartis, GlaxoSmithKline, Almirall & LEO Pharma Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Actinic Keratosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...

Groundbreaking Innovations Drive Actinic Keratosis Treatment Market Growth: $3.89 Billion Market Value Projected by 2027 Dublin, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The "Actinic Keratosis Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The report presents insights into...

U.S. Actinic Keratosis Treatment Market Report 2023: Wide Availability of Treatment Bolsters Sector Growth Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "U.S. Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical/Drugs, Surgery, Photodynamic Therapy), By Drug...

Global Actinic Keratosis Treatment Market Report 2022: High Potential Drugs in Development Pipeline Bode Well for Future Growth Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Global Actinic Keratosis Treatment Market (2022-2027) by Type, End-Users, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff...